VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LNC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LNCLincoln National Corporation
$36.58$7.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLNCQuarterly Financials

Lincoln National Corporation (LNC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Lincoln National Corporation (LNC) quarterly income statement — complete revenue, gross profit & net income history

LNC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue5.31B4.92B4.59B4.07B4.72B5.08B4.2B4.59B4.11B721M4.23B2.93B3.83B4.19B4.8B5.58B4.7B4.56B5.21B4.85B
Revenue Growth %12.51%-3.19%9.36%-11.5%14.66%605.13%-0.66%56.65%7.31%-82.81%-11.96%-47.45%-18.46%-8.01%-7.87%15.01%4.19%6.62%-1.53%33.56%
Medical Costs & Claims2.01B1.93B4.29B4.15B4.27B940M4.07B4.11B4.41B-1.13B4.51B4.27B4.28B1.74B6.85B3.96B4.15B1.27B4.78B3.99B
Medical Cost Ratio %37.86%39.15%93.55%102.07%90.48%18.49%96.97%89.42%107.32%-156.17%106.79%145.5%111.71%41.39%142.65%70.91%88.22%27.88%91.71%82.31%
Gross Profit3.3B3B296M-84M449M4.14B127M486M-301M1.85B-287M-1.33B-449M2.46B-2.05B1.62B554M3.29B432M858M
Gross Margin %62.14%60.85%6.45%-2.07%9.52%81.51%3.03%10.58%-7.32%256.17%-6.79%-45.5%-11.71%58.61%-42.65%29.09%11.78%72.12%8.29%17.69%
Gross Profit Growth %634.3%-27.73%133.07%-117.28%249.17%124.36%144.25%136.43%32.96%-24.86%85.98%-182.19%-181.05%-25.24%-573.84%89.16%74.21%21.51%-9.24%1550%
Operating Expenses3.54B2.08B-228M-932M1.4B2.04B830M-610M-1.83B3.46B-1.32B-1.94B721M2.49B79M591M-1.28B3.05B64M86M
OpEx / Revenue %66.77%42.26%-4.97%-22.93%29.64%40.2%19.77%-13.28%-44.47%480.03%-31.26%-66.03%18.81%59.44%1.65%10.59%-27.25%66.94%1.23%1.77%
Depreciation & Amortization00000000000000000000
Combined Ratio %104.64%81.41%88.59%79.14%120.12%58.69%116.75%76.14%62.85%323.86%75.53%79.47%130.52%100.83%144.29%81.5%60.97%94.82%92.94%84.09%
Operating Income-246M915M524M848M-949M2.1B-703M1.1B1.53B-1.61B1.03B602M-1.17B-35M-2.13B1.03B1.83B236M368M772M
Operating Margin %-4.64%18.59%11.41%20.86%-20.12%41.31%-16.75%23.86%37.15%-223.86%24.47%20.53%-30.52%-0.83%-44.29%18.5%39.03%5.18%7.06%15.91%
Operating Income Growth %74.08%-56.43%174.54%-22.63%-162.11%230.11%-167.99%82.06%230.6%-4511.43%148.64%-41.67%-163.76%-114.83%-677.72%33.68%600.38%165.17%-20%579.5%
EBITDA-165M996M603M848M-869M2.18B-617M1.18B1.61B-1.53B1.12B686M-1.09B43M-2.06B1.1B1.9B302M441M837M
EBITDA Margin %-3.11%20.24%13.13%20.86%-18.43%42.94%-14.7%25.73%39.12%-212.62%26.46%23.4%-28.36%1.03%-42.81%19.72%40.44%6.62%8.46%17.25%
Interest Expense81M81M79M080M83M86M86M81M81M84M84M83M78M71M68M66M66M73M65M
Non-Operating Income-81M-81M-79M0-80M-83M-86M-86M-81M-81M-84M-84M-83M-78M-71M-68M-66M-66M-73M-65M
Pretax Income-246M915M524M848M-949M2.1B-703M1.1B1.53B-1.61B1.03B602M-1.17B-35M-2.13B1.03B1.83B236M368M772M
Pretax Margin %-4.64%18.59%11.41%20.86%-20.12%41.31%-16.75%23.86%37.15%-223.86%24.47%20.53%-30.52%-0.83%-44.29%18.5%39.03%5.18%7.06%15.91%
Income Tax-74M161M79M149M-227M413M-175M201M306M-379M181M91M-289M-41M-350M192M353M16M50M130M
Effective Tax Rate %30.08%17.6%15.08%17.57%23.92%19.67%24.89%18.34%20.03%23.48%17.5%15.12%24.7%117.14%16.46%18.6%19.24%6.78%13.59%16.84%
Net Income-172M754M445M699M-722M1.69B-528M895M1.22B-1.24B853M511M-881M6M-1.78B840M1.48B220M318M642M
Net Margin %-3.24%15.32%9.69%17.2%-15.31%33.18%-12.58%19.49%29.71%-171.29%20.18%17.43%-22.98%0.14%-37%15.06%31.53%4.83%6.1%13.23%
Net Income Growth %76.18%-55.31%184.28%-21.9%-159.08%236.6%-161.9%75.15%238.71%-20683.33%148.03%-39.17%-159.45%-97.27%-658.49%30.84%558.67%53.85%-20.1%782.98%
EPS (Diluted)-0.883.802.123.81-4.419.63-3.295.116.93-7.344.792.94-5.204.76-15.081.390.601.201.683.34
EPS Growth %80.05%-60.54%164.44%-25.44%-163.64%231.2%-168.68%73.81%233.27%-254.2%131.76%111.51%-966.67%296.67%-997.62%-58.38%-48.28%62.16%-16.42%781.63%
EPS (Basic)-0.903.902.153.88-4.419.80-3.295.186.99-7.344.832.96-5.204.80-15.211.390.611.241.703.38
Diluted Shares Outstanding196.3M196.3M194.3M180.6M174.09M174M173.6M171.1M171.1M169.66M170.89M170.5M169.36M170.63M170.66M171.56M173.76M183.33M188.1M191.39M